Huang, Fei <br/><br/>
A novel SGLT2 inhibitor, SU-011, improves glycaemic control in rodents without the risk of hypoglycaemia and weight gain.  [electronic resource] 

 -  The Journal of pharmacy and pharmacology  Sep 2019 
 - 1393-1399 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2042-7158 
<br/><br/><label>Standard No.: </label>10.1111/jphp.13130  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzhydryl Compounds--chemistry<br/>Blood Glucose--drug effects<br/>C-Reactive Protein<br/>Diabetes Mellitus, Experimental--blood<br/>Glucosides--chemistry<br/>HEK293 Cells<br/>Humans<br/>Interleukin-1beta--blood<br/>Male<br/>Mice<br/>Peptide Fragments--blood<br/>Pyrans--chemistry<br/>Sodium-Glucose Transporter 1--antagonists & inhibitors<br/>Sodium-Glucose Transporter 2--metabolism<br/>Sodium-Glucose Transporter 2 Inhibitors--pharmacology<br/>Streptozocin<br/>Tumor Necrosis Factor-alpha--blood